ANA BY EIA (ENZYME LINKED ASSAY), in Visit Clinic

A positive ANA EIA screen means antinuclear antibodies were detected in the blood. It is not diagnostic alone—many autoimmune diseases (e.g., lupus, Sjögren’s, scleroderma) can cause a positive result, but infections, medications, or healthy individuals may also test positive. Follow-up testing (confirmatory immunofluorescence and specific autoantibody panels) and clinical correlation with symptoms are required to determine significance.

A positive ANA test alone usually isn't a reason to panic. Many healthy people have a positive ANA, especially at low titers. Doctors interpret the result with your symptoms, titer and pattern, and may order specific antibody tests or refer to a rheumatologist. If you have joint pain, rashes, fatigue or other suggestive symptoms, follow up; if asymptomatic, your doctor may just monitor.

Antinuclear antibodies (ANA) can be positive in some cancers, notably breast, lung, ovarian and hepatocellular carcinomas, and in hematologic malignancies such as lymphoma and leukemia. ANA positivity is nonspecific, often low-titer, and may reflect paraneoplastic immune responses rather than diagnostic disease; a positive ANA requires further clinical assessment and targeted evaluation when indicated.

ANA (antinuclear antibody) by EIA is a blood test that detects antibodies against cell‑nuclear components using an enzyme immunoassay technique. It’s used to screen for autoimmune diseases such as systemic lupus erythematosus, scleroderma and Sjögren’s syndrome. EIA provides quantitative or qualitative results but can yield false positives; positive findings usually prompt confirmatory testing and clinical correlation.

A positive ANA is not diagnostic. The next step is clinical correlation and targeted testing: specific autoantibodies (anti‑dsDNA, anti‑Sm, anti‑Ro/SSA, anti‑La/SSB, anti‑RNP) and relevant labs (CBC, ESR/CRP, urinalysis for renal involvement). Management depends on symptoms; refer to a rheumatologist if clinical features suggest autoimmune disease or if high‑risk antibodies are present.

A positive ANA is a laboratory finding, not a disease. It can be transient (following infections or certain drugs) and may resolve when the trigger is removed. When linked to an autoimmune condition, ANA itself isn’t “curable”—treatment aims to control inflammation and symptoms; some people achieve remission, but many require long-term monitoring and tailored therapy for the underlying illness.